Press Releases - 2020-11-16

Date	Title	Company
16-Nov-2020	Full results from AFFIRM-AHF study show Ferinject® significantly reduces hospitalizations after acute heart failure in patients with iron deficiency	Vifor Pharma
16-Nov-2020	Precigen Announces Dosing of First Patients with UltraCAR-T® Cells Manufactured Using Proprietary UltraPorator(TM) System in Ongoing PRGN-3005 and PRGN-3006 Phase 1 Clinical Trials	Precigen, Inc.
16-Nov-2020	PTC Therapeutics Highlights Data on High Disease Burden and Value of Treatment Across Two Rare Diseases	PTC Therapeutics, Inc.
16-Nov-2020	Allergan Aesthetics Celebrates Second Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day	AbbVie
16-Nov-2020	Happiness Biotech Starts Offering Kingdomway Coenzyme Q10 in Its Experience Stores	Happiness Biotech Group Limited
16-Nov-2020	PharmAbcine to present the final data of Phase IIa rGBM trial at SNO 2020	PharmAbcine
16-Nov-2020	Astellas to Present New Data on Gilteritinib in FLT3 Mutation-Positive Acute Myeloid Leukemia at the 2020 American Society of Hematology Annual Meeting	Astellas Pharma Inc.
16-Nov-2020	Cygnal Therapeutics Named to Chemical & Engineering News' 10 Start-Ups to Watch List	Cygnal Therapeutics
16-Nov-2020	Q BioMed's Uttroside-B Receives U.S. Patent in Treatment of Liver Cancer	Q BioMed Inc.
16-Nov-2020	Kodiak Sciences Completes Enrollment of DAZZLE Phase 2b/3 Pivotal Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration	Kodiak Sciences Inc.
16-Nov-2020	Calypso Biotech Announces Successful Dosing of First Phase 1 Cohort with Anti-Interleukin-15 (IL-15) Monoclonal Antibody CALY-002 for the Treatment of Autoimmune Diseases	B3C newswire
16-Nov-2020	Lead Pharma Enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases	B3C newswire
16-Nov-2020	Watson-Marlow Limited Ireland announces plans for new facility in Cork	Sciad Newswire
16-Nov-2020	Dermapharm Holding SE continues on its growth course in third quarter of 2020	Dermapharm Holding SE
16-Nov-2020	Lupin Announces FDA Filing Acceptance of Supplemental New Drug Application for Solosec® (secnidazole) for the Treatment of Trichomoniasis	Lupin Pharmaceuticals, Inc.
16-Nov-2020	Cytiva supports Clover Biopharmaceuticals to scale up the output of its vaccine candidate	Cytiva
16-Nov-2020	Cytiva supports Clover Biopharmaceuticals to scale up the output of its vaccine candidate	Cytiva
16-Nov-2020	Healthcare Cybersecurity Market is Forecasted to Hike at 17.3% From 2020 to 2025	Market Data Forecast
16-Nov-2020	Clinical Nutrition Market Size To Grow USD 17.1 Bn BY 2025	Market Data Forecast
16-Nov-2020	Innovent Announces the Results of the Phase I Clinical Trial of IBI302, a First-in-class Ophthalmic Recombinant Human Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2020 American Academy of Ophthalmology	Innovent Biologics, Inc.